Evidence map›Paper›PMID 21216861›Full record

ArticleDiabetes care2011

High rate of regression from micro-macroalbuminuria to normoalbuminuria in children and adolescents with type 1 diabetes treated or not with enalapril: the influence of HDL cholesterol.

Silvana Salardi, Claudia Balsamo, Stefano Zucchini, Giulio Maltoni, Mirella Scipione, Alessandra Rollo, Stefano Gualandi, Alessandro Cicognani

Abstract read
In one paragraph

Article in Diabetes care, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. Hypertension and Diabetic Kidney Disease in Children and Adolescents.Diabetes spectrum : a publication of the American Diabetes Association · 2015
    Article
  9. Article
  10. Diabetic kidney disease in children and adolescents.Pediatric nephrology (Berlin, Germany) · 2015
    Review
  11. Review
  12. Type 1 diabetes and cardiovascular disease.Cardiovascular diabetology · 2013
    Review
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Silvana SalardiDepartment of Pediatrics, S Orsola-Malpighi Hospital, University of Bologna, Bologna, Italy. silvana.salardi@unibo.it
Claudia Balsamo
Stefano Zucchini
Giulio Maltoni
Mirella Scipione
Alessandra Rollo
Stefano Gualandi
Alessandro Cicognani

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo evaluate the frequency of normalization, the persistence of remission, and the impact on normalization of glycemic control and lipid profile, we analyzed data from a retrospective observational cohort study of type 1 diabetic children and adolescents with abnormal urinary albumin excretion (UAE). RESEARCH DESIGN AND

methodsAll diabetic children and adolescents (n = 41) who had persistent abnormal UAE in the period of 1984 to 2008 and followed up until 2009 (follow-up duration = 13.1 ± 6.2 years) were included in the study. Nine patients progressed to macroalbuminuria; 24 patients were administered ACE inhibitor treatment.

resultsThe cumulative prevalence of abnormal UAE was 9%. During follow-up, 14 of 17 untreated and 19 of 24 treated patients reverted to normoalbuminuria. In the remission group compared with the nonremission group, A1C levels during follow-up decreased (7.5 ± 1.0 vs. 9.4 ± 1.2%, P < 0.0001) and serum HDL cholesterol increased (52.7 ± 11.3 vs. 42.7 ± 8.6 mg/dL, P < 0.05). The micro-macroalbuminuric patients had lower HDL cholesterol (51.0 ± 11.4 vs. 62.4 ± 13.6 mg/dL, P < 0.0001) than 134 normoalbuminuric diabetic patients.

conclusionsMicroalbuminuria and macroalbuminuria were not permanent in most of our diabetic children and adolescents. If abnormal UAE values are high and persist for >1 year, only long-lasting treatment with ACE inhibitors seems able to induce persistent remission, especially when associated with good metabolic control and high HDL cholesterol levels.

Indexed as

AdolescentAlbuminuriaAngiotensin-Converting Enzyme InhibitorsChildCholesterol, HDLDiabetes Mellitus, Type 1Diabetic NephropathiesDisease ProgressionEnalaprilFollow-Up StudiesHumansHyperglycemiaLongitudinal StudiesPrevalenceRemission InductionRetrospective StudiesAngiotensin-Converting Enzyme InhibitorsCholesterol, HDLEnalapril

Identifiers

PMID21216861
PMCPMC3024361

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.